Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT05027256
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years old at the time of study entry
* Can provide written informed consent
* Patients who are currently receiving standard of care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy and have received at least one cycle
* Sufficient hearing to be able to participate in a video training session
Exclusion Criteria:
* Known inherited or acquired bleeding disorder
* History of haematological malignancy
* Known poorly controlled anti-coagulation
* Inadequate use and understanding of the English language, requiring a translator
* Participant unlikely to be able to perform fine manipulation required to use lancet or cartridge to obtain capillary blood sample and result
* Previously taken part in the 'PERTH-2' study involving a prototype device
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05027256
Study Brief:
Protocol Section:
NCT05027256